Cargando…

Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models

Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline...

Descripción completa

Detalles Bibliográficos
Autor principal: Välitalo, Pyry Antti Juhana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405508/
https://www.ncbi.nlm.nih.gov/pubmed/34159497
http://dx.doi.org/10.1007/s10928-021-09760-1
_version_ 1783746349859078144
author Välitalo, Pyry Antti Juhana
author_facet Välitalo, Pyry Antti Juhana
author_sort Välitalo, Pyry Antti Juhana
collection PubMed
description Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline several methods for using aggregate data as the basis of parameter estimation. The presented methods can be used for estimation of parameters from aggregate data, and as a computationally efficient alternative for the stochastic simulation and estimation procedure. They also allow for population PK/PD optimal design in the case when the data-generating model is different from the data-analytic model, a scenario for which no solutions have previously been available. Mathematical analysis and computational results confirm that the aggregate-data FO algorithm converges to the same estimates as the individual-data FO and yields near-identical standard errors when used in optimal design. The aggregate-data MC algorithm will asymptotically converge to the exactly correct parameter estimates if the data-generating model is the same as the data-analytic model. The performance of the aggregate-data methods were also compared to stochastic simulations and estimations (SSEs) when the data-generating model is different from the data-analytic model. The aggregate-data FO optimal design correctly predicted the sampling distributions of 200 models fitted to simulated datasets with the individual-data FO method. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-021-09760-1.
format Online
Article
Text
id pubmed-8405508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-84055082021-09-09 Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models Välitalo, Pyry Antti Juhana J Pharmacokinet Pharmacodyn Original Paper Lack of data is an obvious limitation to what can be modelled. However, aggregate data in the form of means and possibly (co)variances, as well as previously published pharmacometric models, are often available. Being able to use all available data is desirable, and therefore this paper will outline several methods for using aggregate data as the basis of parameter estimation. The presented methods can be used for estimation of parameters from aggregate data, and as a computationally efficient alternative for the stochastic simulation and estimation procedure. They also allow for population PK/PD optimal design in the case when the data-generating model is different from the data-analytic model, a scenario for which no solutions have previously been available. Mathematical analysis and computational results confirm that the aggregate-data FO algorithm converges to the same estimates as the individual-data FO and yields near-identical standard errors when used in optimal design. The aggregate-data MC algorithm will asymptotically converge to the exactly correct parameter estimates if the data-generating model is the same as the data-analytic model. The performance of the aggregate-data methods were also compared to stochastic simulations and estimations (SSEs) when the data-generating model is different from the data-analytic model. The aggregate-data FO optimal design correctly predicted the sampling distributions of 200 models fitted to simulated datasets with the individual-data FO method. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-021-09760-1. Springer US 2021-06-22 2021 /pmc/articles/PMC8405508/ /pubmed/34159497 http://dx.doi.org/10.1007/s10928-021-09760-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Välitalo, Pyry Antti Juhana
Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title_full Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title_fullStr Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title_full_unstemmed Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title_short Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
title_sort pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405508/
https://www.ncbi.nlm.nih.gov/pubmed/34159497
http://dx.doi.org/10.1007/s10928-021-09760-1
work_keys_str_mv AT valitalopyryanttijuhana pharmacometricestimationmethodsforaggregatedataincludingdatasimulatedfromotherpharmacometricmodels